Address: Park LifeScience
ul. Bobrzyńskiego 14,
30-348 Kraków, Polska
Tel: +48 12 297 4605
Web: http://lifescience.pl/content.php?component=com_publisher§ion_id=1
The Krakow LifeScience Network is made up of like-minded companies and organisations in the Krakow area dedicated to bringing the best bio-business services and products to a global market. It is formed as The Project/Initiative.
Jagiellonian Centre of Innovation Ltd (the Partner in the initiative) manages the network in order to maintain its ongoing activities and quality service levels.
The management position has been appointed to secure realisation of stated goals, which include the following:
to be the single point of contact for ease of making relationships and exploring business and scientific collaborations,
to facilitate introductions to the network members from the global market,
get the network members ready to effectively engage wit the global lifescience market.
To create and sustain The Life Science Network to enable effective global connectivity and optimisation of existing pottential of individuals and organisations.
To support innovation and to encourage effective commercialization of results of research in the Life Science field.
To develop the resources and competences in the Life Science sector in order to effectively explore current existing and future opportunities related to development of a knowledge based economy.
Poland has an important manufacturing role for the CEE region and this is where Mylan has settled Agila, a state-of-the-art, high quality injectables manufacturing platform. Mylan has great ambitions in…
GSK Poland’s General Manager, Jerzy Toczyski, explains the reasons behind acquiring a state-of-the-art manufacturing facility in Poland, as well as the need to implement leaner manufacturing processes to become more…
GSK Poland’s General Manager, Jerzy Toczyski, explains the reasons behind acquiring a state-of-the-art manufacturing facility in Poland, as well as the need to implement leaner manufacturing processes to become more…
GSK Poland’s General Manager, Jerzy Toczyski, explains the reasons behind acquiring a state-of-the-art manufacturing facility in Poland, as well as the need to implement leaner manufacturing processes to become more…
Selvita is one of Poland’s R&D jewels, and its co-founder and CEO, Paweł Przewięźlikowski, strongly wishes that others would join their efforts in finally raising Poland’s footprint in R&D. He…
Selvita is one of Poland’s R&D jewels, and its co-founder and CEO, Paweł Przewięźlikowski, strongly wishes that others would join their efforts in finally raising Poland’s footprint in R&D. He…
Selvita is one of Poland’s R&D jewels, and its co-founder and CEO, Paweł Przewięźlikowski, strongly wishes that others would join their efforts in finally raising Poland’s footprint in R&D. He…
Sanofi’s General Manager in Poland, Marynika Woroszylska-Sapieha, shares two very important concepts that showcase the situation in Poland, stating that: “The biggest obstacle to innovation in Poland is the threshold…
“Average pharmaceutical company expenditures on R&D are in the range of 13 to 15 percent of revenues: much higher than the global average, and much higher than other Polish industrial…
“The swelling influence of wholesalers in the market frightens me.” With three wholesalers in Poland holding 80 percent of the market and establishing their own brands in a changing environment,…
“Instead of creating a state pharmaceutical duopoly, we have created an environment where the pharma industry can introduce new products and market them enthusiastically. This creates a market where pharmaceutical…
Persistence is a blessing, explains Glenmark’s Country Manager for Poland, Andrzej Gondek. By adapting a new product strategy to increase their OTC portfolio, Glenmark managed to nearly double its sales…
See our Cookie Privacy Policy Here
